| Control N=10 | p-value* Control vs Preclinical | Preclinical HCM N=30 | p-value* Preclinical vs Overt | Overt HCM N=37 | p-value* Control vs Overt |
---|---|---|---|---|---|---|
ECV (range) | 0.26 ± 0.01 (0.24-0.31) | <0.001 | 0.33 ± 0.01 (0.23-0.38) | <0.001 | 0.37 ± 0.01 (0.31-0.51) | <0.001 |
ECV, excluding LGE | 0.26 ± 0.01 | <0.001 | 0.33 ± 0.01 | <0.001 | 0.37 ± 0.01 | <0.001 |
LGE present, % (#yes / #no) | 0% (0/10) | Â | 0% (0/29) | Â | 78.4% (29/8) | Â |
LGE, g | 0 | 0.8 | 0 | 0.004 | 16.7 ± 4.9 | 0.003 |
LGE, % LV mass | 0 | 0.7 | 0 | 0.0006 | 7.76 ± 1.96 (0.9-44.6%) | 0.001 |
PICP, μg/L | 63.08 ± 4.19 | <0.001 | 83.81 ± 4.39 | 0.035 | 108.04 ± 9.81 | <0.001 |